Articles Tagged With: vaccine
-
Pediatric Tuberculosis
Mycobacterium tuberculosis (MTB) is a significant challenge to children's health. Barriers exist at multiple levels of the care system for MTB. Early recognition and involvement of MTB specialists is critical to facilitate the best outcome for pediatric patients. The authors provide a thorough review of the current standards for care of these challenging patients.
-
Regulators Sign Off on COVID-19 Vaccine ‘Mix and Match’
Federal agencies expand, clarify guidance on booster shots.
-
Adjuvanted Zoster Vaccine: Persistent Protection
The adjuvanted recombinant zoster vaccine efficacy is high and persistent, with apparent plateauing at > 84% four to six years after vaccination.
-
Malaria: At Last a Vaccine
The World Health Organization has recommended the use of the first effective malaria vaccine.
-
COVID-19 Vaccination and Myocarditis
Receipt of a COVID-19 mRNA vaccine is associated with a small but real risk of development of myocarditis, predominantly in young males. The vast majority of cases are mild, self-limited, and require no intervention.
-
The Return of Flu: Signs Point to Possible Severe Season
A possible severe influenza season is on the horizon, in part because COVID-19 shutdowns and precautions led to a historically low flu season in 2019-2020, said Rochelle Walensky, MD, director of the Centers for Disease Control and Prevention.
-
Adjuvanted Zoster Vaccine: Persistent Protection
The adjuvanted recombinant zoster vaccine efficacy is high and persistent, with apparent plateauing at > 84% four to six years after vaccination.
-
Emerging Options for Malaria Prevention
New data suggest that combining vaccination with chemoprophylaxis is better than either intervention alone, and a small pilot study suggests that a monoclonal antibody infusion is effective in preventing malaria infections.
-
COVID-19 Vaccine mRNA Injection (Comirnaty)
Comirnaty is the first COVID-19 vaccine to receive full FDA approval.
-
COVID-19 Vaccination: The Heart of the Matter
The occurrence of myocarditis after receipt of COVID-19 vaccines is most frequent in young men and generally benign, with rapid resolution only through supportive care. Careful analysis indicates the benefit of vaccination outweighs the risk in all groups for whom the vaccine is recommended.